Skip to content
Screener

Medpace Holdings, Inc. MEDP Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$33M-14.5%
IQVIA logo
IQVIAIQV
$50M+35.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$38M-19.8%
Simulations Plus logo
Simulations PlusSLP
$59K-76.9%
RFL
Rafael Holdings, Inc.RFL
$245K0.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.81B+33.1%
Enterprise value$16.46B+29.2%
P/E34.2×+4.0×
P/S+0.4×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemAs of / June 30,2026As of / December 31,2025
Accounts receivable$420,560$376,755
Unbilled receivables21,26525,352
Less: allowance for doubtful accounts(28)(29)
Total accounts receivable and unbilled, net$441,797$402,078

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current)?
Medpace Holdings, Inc. (MEDP) reported allowance for doubtful accounts receivable (current) of $28K in Q2 2026.
What is the long-term trend for Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current)?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current) has grown at a -35.8% compound annual growth rate (CAGR), from $171K to $29K.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Medpace Holdings, Inc.'s allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude